See more : Suzlon Energy Limited (SUZLON.NS) Income Statement Analysis – Financial Results
Complete financial analysis of SenesTech, Inc. (SNES) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SenesTech, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Bank of India Limited (BANKINDIA.BO) Income Statement Analysis – Financial Results
- Pharol, SGPS S.A. (PHR.LS) Income Statement Analysis – Financial Results
- NVIDIA Corporation (NVDA) Income Statement Analysis – Financial Results
- tinyBuild, Inc. (TBLD.L) Income Statement Analysis – Financial Results
- Sama Resources Inc. (SME.V) Income Statement Analysis – Financial Results
SenesTech, Inc. (SNES)
About SenesTech, Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19M | 1.02M | 576.00K | 258.00K | 143.00K | 297.00K | 52.00K | 318.00K | 241.00K | 199.00K |
| Cost of Revenue | 654.00K | 555.00K | 356.00K | 281.00K | 101.00K | 241.00K | 45.00K | 196.00K | 0.00 | 0.00 |
| Gross Profit | 539.00K | 464.00K | 220.00K | -23.00K | 42.00K | 56.00K | 7.00K | 122.00K | 241.00K | 199.00K |
| Gross Profit Ratio | 45.18% | 45.53% | 38.19% | -8.91% | 29.37% | 18.86% | 13.46% | 38.36% | 100.00% | 100.00% |
| Research & Development | 1.23M | 1.86M | 1.95M | 1.49M | 1.91M | 2.40M | 3.19M | 2.71M | 7.22M | 3.20M |
| General & Administrative | 6.70M | 7.59M | 7.22M | 6.44M | 0.00 | 9.53M | 9.13M | 8.13M | 8.67M | 2.70M |
| Selling & Marketing | 317.00K | 631.00K | 584.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.02M | 8.28M | 7.22M | 6.44M | 8.42M | 9.53M | 9.13M | 8.13M | 8.67M | 2.70M |
| Other Expenses | 27.00K | -26.00K | -24.00K | -24.00K | 266.00K | 21.00K | 87.00K | -31.00K | -678.00K | 31.00K |
| Operating Expenses | 8.27M | 10.14M | 9.15M | 7.91M | 10.33M | 11.94M | 12.32M | 10.83M | 15.89M | 5.90M |
| Cost & Expenses | 8.93M | 10.69M | 9.51M | 8.19M | 10.43M | 12.18M | 12.37M | 10.83M | 15.89M | 5.90M |
| Interest Income | 26.00K | 7.00K | 4.00K | 3.00K | 45.00K | 25.00K | 29.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.00K | 2.00K | 11.00K | 28.00K | 42.00K | 74.00K | 86.00K | 87.00K | 855.00K | 632.00K |
| Depreciation & Amortization | 135.00K | 183.00K | 303.00K | 288.00K | 413.00K | 447.00K | 391.00K | 196.00K | 182.00K | 125.00K |
| EBITDA | -7.57M | -9.51M | -7.95M | -7.62M | -9.56M | -11.39M | -11.81M | -10.51M | -17.14M | -6.44M |
| EBITDA Ratio | -634.62% | -951.23% | -1,550.35% | -3,065.50% | -6,687.41% | -3,834.01% | -22,709.62% | -3,255.03% | -6,697.51% | -2,784.42% |
| Operating Income | -7.73M | -9.67M | -8.93M | -7.93M | -10.29M | -11.88M | -12.32M | -10.52M | -15.65M | -5.70M |
| Operating Income Ratio | -648.11% | -949.36% | -1,551.04% | -3,074.81% | -7,193.71% | -4,000.00% | -23,684.62% | -3,306.92% | -6,491.70% | -2,862.81% |
| Total Other Income/Expenses | 22.00K | -21.00K | 666.00K | -4.00K | 269.00K | -28.00K | 30.00K | -279.00K | -2.53M | -1.50M |
| Income Before Tax | -7.71M | -9.70M | -8.27M | -7.94M | -10.02M | -11.91M | -12.29M | -10.80M | -18.17M | -7.20M |
| Income Before Tax Ratio | -646.27% | -951.42% | -1,435.42% | -3,076.36% | -7,005.59% | -4,009.43% | -23,626.92% | -3,394.65% | -7,540.66% | -3,618.09% |
| Income Tax Expense | 0.00 | 19.00K | -292.00K | -239.00K | 308.00K | 46.00K | 173.00K | 56.00K | 177.00K | 663.00K |
| Net Income | -7.71M | -9.71M | -7.98M | -7.70M | -10.33M | -11.91M | -12.29M | -10.80M | -18.17M | -7.20M |
| Net Income Ratio | -646.27% | -953.29% | -1,384.72% | -2,983.72% | -7,220.98% | -4,009.43% | -23,626.92% | -3,394.65% | -7,540.66% | -3,618.09% |
| EPS | -11.51 | -186.39 | -171.04 | -614.56 | -1.90K | -245.50 | -450.00 | -672.84 | -1.09K | -403.93 |
| EPS Diluted | -115.10 | -186.39 | -171.04 | -614.56 | -1.90K | -245.50 | -450.00 | -672.84 | -1.09K | -403.93 |
| Weighted Avg Shares Out | 669.85K | 52.12K | 46.63K | 12.53K | 5.43K | 48.51K | 27.30K | 16.04K | 16.65K | 17.83K |
| Weighted Avg Shares Out (Dil) | 66.99K | 52.12K | 46.63K | 12.53K | 5.43K | 48.51K | 27.30K | 16.04K | 16.65K | 17.83K |
Tomslist: The 5 Weirdest Penny Stock Stories of the Week
Even the best penny stocks have their dog days. Here's a celebration of this week's weirdest plays: SNES, IDRA, SOS, TSNPD and HLLPF.
SenesTech, Inc. Announces $3.95 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
PHOENIX, March 19, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced that it has entered into securities purchase agreements with several institutional investors for the...
SNES Stock News: Why Biotech Company SenesTech Is Skyrocketing Today
SenesTech (SNES) stock is flying high on Friday after announcing successful trials of its new pest control products at poultry facilities. The post SNES Stock News: Why Biotech Company SenesTech Is Skyrocketing Today appeared first on InvestorPlace.
SenesTech Announces Successful Completion of a Long Term Agricultural Deployment of ContraPest®
PHOENIX, March 18, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the conclusion of agricultural deployments of ContraPest® with demonstrated, sustained success in reducing rat...
SenesTech to Report Fourth Quarter and Fiscal Year 2020 Financial Results on Thursday, March 25, 2021
PHOENIX, March 17, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its fourth quarter and fiscal year 2020, ended December 31, 2020, after...
SenesTech, Inc. Announces Closing of $10 Million Private Placement Priced At-the-Market
PHOENIX, Feb. 2, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the closing of its previously announced private placement of 4,388,854 shares of...
SenesTech, Inc. Announces $10 Million Private Placement Priced At-the-Market
PHOENIX, Jan. 27, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced that it has entered into securities purchase agreements with certain...
SenesTech, Inc. (SNES) CEO Ken Siegel on Q3 2020 Results - Earnings Call Transcript
SenesTech, Inc. (SNES) CEO Ken Siegel on Q3 2020 Results - Earnings Call Transcript
The Best SNES Emulators for 2020 | Digital Trends
Playing games from past generations doesn't have to be an exercise in futility. These SNES emulators let you easily access every game on the classic system.
Source: https://incomestatements.info
Category: Stock Reports